98 related articles for article (PubMed ID: 6241500)
1. Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids.
Lefer AM; Burke SE; Lepran I
Can J Physiol Pharmacol; 1984 Dec; 62(12):1487-91. PubMed ID: 6241500
[TBL] [Abstract][Full Text] [Related]
2. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
[TBL] [Abstract][Full Text] [Related]
3. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
Brezinski ME; Yanagisawa A; Darius H; Lefer AM
Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
[TBL] [Abstract][Full Text] [Related]
4. Preservation of ischemic myocardium by pinane thromboxane A2.
Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death.
Burke SE; Roth DM; Lefer AM
Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596
[TBL] [Abstract][Full Text] [Related]
6. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.
Smith EF; Lefer AM; Smith JB
Can J Physiol Pharmacol; 1980 Mar; 58(3):294-300. PubMed ID: 7378931
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
Osborne JA; Lefer AM
Am J Physiol; 1988 Aug; 255(2 Pt 2):H318-24. PubMed ID: 2970233
[TBL] [Abstract][Full Text] [Related]
8. Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor.
Burke SE; DiCola G; Lefer AM
J Cardiovasc Pharmacol; 1983; 5(5):842-7. PubMed ID: 6195474
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia.
Brezinski ME; Yanagisawa A; Lefer AM
J Cardiovasc Pharmacol; 1987 Jan; 9(1):65-71. PubMed ID: 2434797
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
Schrör K; Thiemermann C
Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion.
Ma XL; Weyrich AS; Krantz S; Lefer AM
J Pharmacol Exp Ther; 1992 Mar; 260(3):1229-36. PubMed ID: 1545390
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Bhat AM; Sacks H; Osborne JA; Lefer AM
Am Heart J; 1989 Apr; 117(4):799-803. PubMed ID: 2929397
[TBL] [Abstract][Full Text] [Related]
13. Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats.
Johnson G; Furlan LE; Aoki N; Lefer AM
Circ Res; 1990 May; 66(5):1362-70. PubMed ID: 2159389
[TBL] [Abstract][Full Text] [Related]
14. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
Bitterman H; Yanagisawa A; Lefer AM
Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
[TBL] [Abstract][Full Text] [Related]
15. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
Ogletree ML; Lefer AM; Smith JB; Nicolaou KC
Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
[TBL] [Abstract][Full Text] [Related]
16. The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
Thiemermann C; Ney P; Schrör K
Eur J Pharmacol; 1988 Oct; 155(1-2):57-67. PubMed ID: 2977337
[TBL] [Abstract][Full Text] [Related]
17. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
Johnson G; Tsao PS; Mulloy D; Lefer AM
J Pharmacol Exp Ther; 1990 Jan; 252(1):35-41. PubMed ID: 2153807
[TBL] [Abstract][Full Text] [Related]
19. BM 13.505, a selective thromboxane receptor antagonist, reduces myocardial infarct size following coronary artery reperfusion.
Smith EF; Earl CQ; Egan JW
Prostaglandins Leukot Essent Fatty Acids; 1989 Oct; 38(1):15-23. PubMed ID: 2532749
[TBL] [Abstract][Full Text] [Related]
20. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
